Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Brans B, Bodei L, Giammarile F, Linden O, Luster M, Oyen WJG, et al. Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”. Eur J Nucl Med Mol Imag 2007;34:772–86.CrossRef
2.
Seidlin SM, Marinelli MD, Oshry E. Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of thyroid. J Am Med Assoc 1946;132:838–47.
3.
Wiseman GA, White CA, Sparks RB, Erwin WD, Podoloff DA, Lamonica D, et al. Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin’s lymphoma. Crit Rev Oncol Hematol 2001;39(1–2):181–94.PubMedCrossRef
4.
Matthay KK, Panina C, Huberty J, Price D, Glidden DV, Tang HR, et al. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma. treated with I-131-MIBG. J Nucl Med 2001;42(11):1713–21.PubMed
5.
Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, et al. Patient-specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 2004;45(8):1366–72.PubMed
6.
Hänscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, et al. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med 2006;47(4):648–54.PubMed
7.
ICRU report 67. Dose specifications in nuclear medicine. ICRU 2002.
8.
Health protection of individuals against the dangers of ionising radiation in relation to medical exposure: Council directive 97/43 EURATOM 1997.
Metadata
Title
Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
Authors
Glenn Flux
Manuel Bardies
Carlo Chiesa
Myriam Monsieurs
Sauli Savolainen
Sven-Erik Strand
Michael Lassmann
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 10/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0471-9

Other articles of this Issue 10/2007

European Journal of Nuclear Medicine and Molecular Imaging 10/2007 Go to the issue

Book review

G. Schmidt. Thieme clinical companions: ultrasound, 5th edition.

Original Article

Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy

Letter to the Editor

Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules

Book review

Habib Zaidi: Quantitative Analysis in Nuclear Medicine Imaging

Image of the month

Diagnosis of endoneural sciatic nerve invasion by uterine cervical epidermoid cancer using [18F]FDG-PET/CT

Focus on...

Imaging biomarkers: from research to patient care—a shift in view